FDA Inspection 650762 — Janzen, Mark A. Ph.D., Clinical Investigator
The FDA completed an inspection of Janzen, Mark A. Ph.D., Clinical Investigator on Mar 9, 2010 in Saint Paul, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 9, 2010
- Fiscal Year
- 2010
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Saint Paul, MN (United States)
Additional Details
Clinical Investigator (CI)